Portfolio Holdings Detail for ISIN IE00BGPP8L80
Stock Name / Fund iShares Edge MSCI World Minimum Volatility UCITS ETF GBP Hedged (Acc)
Issuer Blackrock
Entity holding fund iShares VI Public Limited Company
Entity Type
Entity LEI 549300VML6THE3JJOS76
ETF Ticker WMVG(GBP) LSE
ETF Ticker WMVG.L(GBP) LSE

Holdings detail for NBIX

Stock Name	Neurocrine Biosciences Inc
Ticker	NBIX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US64125C1099
LEI	549300FECER0XBN49756

Show aggregate NBIX holdings

News associated with NBIX

Sum Up The Parts: SCHG Could Be Worth $34: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-21 10:23:31
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Maryland State Retirement & Pension System: Maryland State Retirement & Pension System lowered its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 12.5% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,661 shares of the company’s stock after selling 663 shares during the quarter. Maryland […] - 2025-08-15 05:24:56
Charles Schwab Investment Management Inc. Purchases 13,216 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX): Charles Schwab Investment Management Inc. raised its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.7% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 775,773 shares of the company’s stock after acquiring an additional 13,216 shares during the quarter. Charles […] - 2025-08-13 05:10:46
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Blair William & Co. IL: Blair William & Co. IL cut its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 3.7% in the first quarter, Holdings Channel reports. The fund owned 6,214 shares of the company’s stock after selling 242 shares during the period. Blair William & Co. IL’s holdings in Neurocrine Biosciences were worth $687,000 at the […] - 2025-08-11 05:52:52
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Federated Hermes Inc.: Federated Hermes Inc. trimmed its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 72.9% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 9,441 shares of the company’s stock after selling 25,402 shares during the quarter. Federated Hermes Inc.’s […] - 2025-08-07 05:22:58
Natixis Advisors LLC Sells 292 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX): Natixis Advisors LLC lowered its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 0.9% in the first quarter, Holdings Channel.com reports. The institutional investor owned 33,312 shares of the company’s stock after selling 292 shares during the period. Natixis Advisors LLC’s holdings in Neurocrine Biosciences were worth $3,684,000 at the end of the […] - 2025-08-07 04:49:07
Neurocrine (NBIX) Q2 2025 Earnings Call Transcript: @media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo - 2025-08-05 01:16:10
Neurocrine (NBIX) Q2 Revenue Jumps 17%: Key PointsNon-GAAP earnings per share of $1.65 for Q2 2025 vastly exceeded the analyst estimate of $0.96. - 2025-08-01 01:15:16
13,202 Shares in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Bought by Y Intercept Hong Kong Ltd: Y Intercept Hong Kong Ltd acquired a new position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) in the 1st quarter, HoldingsChannel.com reports. The fund acquired 13,202 shares of the company’s stock, valued at approximately $1,460,000. Other hedge funds and other institutional investors have also recently bought and sold shares of the company. […] - 2025-07-24 06:50:57
HighPoint Advisor Group LLC Purchases 366 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX): HighPoint Advisor Group LLC boosted its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 15.0% during the first quarter, Holdings Channel.com reports. The fund owned 2,812 shares of the company’s stock after acquiring an additional 366 shares during the quarter. HighPoint Advisor Group LLC’s holdings in Neurocrine Biosciences were worth $302,000 […] - 2025-07-24 05:51:14
Neurocrine Biosciences (NASDAQ:NBIX) Now Covered by Analysts at Truist Financial: Truist Financial initiated coverage on shares of Neurocrine Biosciences (NASDAQ:NBIX – Free Report) in a research report report published on Monday, Marketbeat reports. The firm issued a buy rating and a $163.00 price target on the stock. NBIX has been the subject of several other reports. Royal Bank Of Canada reaffirmed an “outperform” rating and […] - 2025-07-22 04:28:48
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Position Trimmed by Cerity Partners LLC: Cerity Partners LLC decreased its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 20.1% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 33,361 shares of the company’s stock after selling 8,376 shares during the quarter. Cerity Partners LLC’s holdings in […] - 2025-07-18 04:55:08
Ingrid Delaet Sells 457 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock: Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) insider Ingrid Delaet sold 457 shares of the business’s stock in a transaction on Thursday, July 10th. The stock was sold at an average price of $135.00, for a total transaction of $61,695.00. Following the completion of the transaction, the insider directly owned 4,730 shares in the […] - 2025-07-14 07:16:47
Bank of New York Mellon Corp Has $91.65 Million Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX): Bank of New York Mellon Corp lessened its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 4.8% during the first quarter, HoldingsChannel reports. The fund owned 828,682 shares of the company’s stock after selling 41,608 shares during the quarter. Bank of New York Mellon Corp’s holdings in Neurocrine Biosciences were worth $91,652,000 as […] - 2025-07-11 05:40:57
Principal Financial Group Inc. Has $27.48 Million Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX): Principal Financial Group Inc. reduced its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.6% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 248,420 shares of the company’s stock after selling 4,049 shares during the period. Principal Financial Group Inc. owned 0.25% of Neurocrine Biosciences […] - 2025-07-09 05:51:40
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Given Average Recommendation of “Moderate Buy” by Analysts: Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the twenty-two brokerages that are presently covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and nineteen have given a buy recommendation to the company. The average 12 […] - 2025-07-09 03:09:50
First Horizon Advisors Inc. Has $43,000 Stock Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX): First Horizon Advisors Inc. decreased its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 55.5% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 385 shares of the company’s stock after selling 480 shares during the quarter. First Horizon Advisors […] - 2025-07-08 05:49:06
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Insider Jude Onyia Sells 20,362 Shares: Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Get Free Report) insider Jude Onyia sold 20,362 shares of the company’s stock in a transaction on Wednesday, July 2nd. The stock was sold at an average price of $130.13, for a total value of $2,649,707.06. Following the completion of the sale, the insider owned 18,289 shares of the company’s […] - 2025-07-08 05:06:50
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by KBC Group NV: KBC Group NV lessened its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 3.5% in the 1st quarter, Holdings Channel reports. The fund owned 13,835 shares of the company’s stock after selling 495 shares during the period. KBC Group NV’s holdings in Neurocrine Biosciences were worth $1,530,000 as of its most recent filing […] - 2025-07-04 06:58:45
New York State Teachers Retirement System Lowers Stock Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX): New York State Teachers Retirement System lowered its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.9% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 108,481 shares of the company’s stock after selling 2,055 shares during the quarter. New York State Teachers Retirement System’s holdings in Neurocrine Biosciences were worth $11,998,000 […] - 2025-07-04 06:14:58
Amalgamated Bank Has $5.28 Million Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX): Amalgamated Bank lessened its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 3.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 47,719 shares of the company’s stock after selling 1,895 shares during the quarter. Amalgamated Bank’s holdings in Neurocrine Biosciences were […] - 2025-07-03 06:14:49
Sumitomo Mitsui Trust Group Inc. Sells 1,399 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX): Sumitomo Mitsui Trust Group Inc. reduced its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 0.6% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 231,458 shares of the company’s stock after selling 1,399 shares during the quarter. Sumitomo Mitsui Trust […] - 2025-07-03 05:35:01
Golden State Wealth Management LLC Grows Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX): Golden State Wealth Management LLC increased its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 116.9% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 397 shares of the company’s stock after purchasing an additional 214 shares during the quarter. […] - 2025-07-02 05:01:01
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Acquired by Oppenheimer & Co. Inc.: Oppenheimer & Co. Inc. raised its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 2.4% in the 1st quarter, HoldingsChannel.com reports. The fund owned 19,388 shares of the company’s stock after buying an additional 447 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Neurocrine Biosciences were worth $2,144,000 as […] - 2025-06-27 05:10:49
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Sold by Retirement Systems of Alabama: Retirement Systems of Alabama cut its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 1.4% in the 1st quarter, Holdings Channel reports. The firm owned 121,352 shares of the company’s stock after selling 1,755 shares during the period. Retirement Systems of Alabama’s holdings in Neurocrine Biosciences were worth $13,422,000 at the […] - 2025-06-23 05:04:51
Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Shares Bought by QRG Capital Management Inc.: QRG Capital Management Inc. lifted its position in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 7.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 20,062 shares of the company’s stock after buying an additional 1,330 shares […] - 2025-06-20 06:54:59
Sowell Financial Services LLC Takes Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX): Sowell Financial Services LLC bought a new stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm bought 4,786 shares of the company’s stock, valued at approximately $529,000. Other institutional investors and hedge funds […] - 2025-06-20 05:29:06
Trust Point Inc. Sells 660 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX): Trust Point Inc. decreased its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 26.6% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,823 shares of the company’s stock after selling 660 shares during the period. Trust Point Inc.’s holdings in […] - 2025-06-19 05:35:02
XBI, EXAS, NBIX, NTRA: ETF Outflow Alert: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $443.9 million dollar outflow -- that's a 8.8% decrease week over week - 2025-06-17 11:54:37
Merit Financial Group LLC Acquires 345 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX): Merit Financial Group LLC raised its position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 9.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,153 shares of the company’s stock after purchasing an additional 345 shares during the quarter. Merit Financial Group […] - 2025-06-11 05:00:51

iShares Edge MSCI World Minimum Volatility UCITS ETF GBP Hedged (Acc) NBIX holdings

Date	Number of NBIX Shares Held	Base Market Value of NBIX Shares	Local Market Value of NBIX Shares	Change in NBIX Shares Held	Change in NBIX Base Value	Current Price per NBIX Share Held	Previous Price per NBIX Share Held
2025-11-10 (Monday)	22,009	USD 3,301,790	USD 3,301,790	0	USD -51,721	USD 150.02	USD 152.37
2025-11-07 (Friday)	22,009	USD 3,353,511	USD 3,353,511	0	USD -53,482	USD 152.37	USD 154.8
2025-11-06 (Thursday)	22,009	USD 3,406,993	USD 3,406,993	0	USD 23,109	USD 154.8	USD 153.75
2025-11-05 (Wednesday)	22,009	USD 3,383,884	USD 3,383,884	0	USD 232,415	USD 153.75	USD 143.19
2025-11-04 (Tuesday)	22,009	USD 3,151,469	USD 3,151,469	-220	USD -4,160	USD 143.19	USD 141.96
2025-11-03 (Monday)	22,229	USD 3,155,629	USD 3,155,629	0	USD -27,786	USD 141.96	USD 143.21
2025-10-31 (Friday)	22,229	USD 3,183,415	USD 3,183,415	104	USD 129,280	USD 143.21	USD 138.04
2025-10-30 (Thursday)	22,125	USD 3,054,135	USD 3,054,135	0	USD 442	USD 138.04	USD 138.02
2025-10-29 (Wednesday)	22,125	USD 3,053,693	USD 3,053,693	0	USD -207,090	USD 138.02	USD 147.38
2025-10-28 (Tuesday)	22,125	USD 3,260,783	USD 3,260,783	-208	USD -65,494	USD 147.38	USD 148.94
2025-10-27 (Monday)	22,333	USD 3,326,277	USD 3,326,277	0	USD 110,325	USD 148.94	USD 144
2025-10-24 (Friday)	22,333	USD 3,215,952	USD 3,215,952	0	USD 7,370	USD 144	USD 143.67

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of NBIX by Blackrock for IE00BGPP8L80

Show aggregate share trades of NBIX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-04 SELL -220 143.870 140.820 141.125 USD -31,048 124.42 Loss of -3,676 on sale
2025-10-31 BUY 104 143.470 137.065 137.706 USD 14,321 124.25
2025-10-28 SELL -208 147.380 149.980 149.720 USD -31,142 124.01 Loss of -5,348 on sale
2025-10-21 SELL -208 142.650 142.970 142.938 USD -29,731 123.52 Loss of -4,039 on sale
2025-10-14 SELL -104 137.230 138.600 138.463 USD -14,400 123.14 Loss of -1,594 on sale
2025-10-02 SELL -414 136.740 137.630 137.541 USD -56,942 122.92 Loss of -6,054 on sale
2025-09-25 SELL -104 140.890 145.610 145.138 USD -15,094 122.47 Loss of -2,357 on sale
2025-09-16 BUY 95 140.900 141.020 141.008 USD 13,396 122.15
2025-09-12 SELL -412 141.870 144.040 143.823 USD -59,255 121.94 Loss of -9,014 on sale
2025-09-09 SELL -226 144.170 144.210 144.206 USD -32,591 121.60 Loss of -5,108 on sale
2025-07-28 SELL -251 133.710 134.440 134.367 USD -33,726 120.61 Loss of -3,453 on sale
2025-07-15 SELL -928 131.240 136.250 135.749 USD -125,975 120.25 Loss of -14,380 on sale
2025-07-11 SELL -464 133.460 135.000 134.846 USD -62,569 120.08 Loss of -6,850 on sale
2025-07-07 BUY 2,366 127.880 129.070 128.951 USD 305,098 119.81
2025-07-02 BUY 223 129.400 130.420 130.318 USD 29,061 119.63
2025-06-30 SELL -675 125.690 127.360 127.193 USD -85,855 119.59 Loss of -5,130 on sale
2025-06-27 SELL -741 125.420 127.260 127.076 USD -94,163 119.56 Loss of -5,573 on sale
2025-06-26 BUY 225 126.710 128.660 128.465 USD 28,905 119.51
2025-06-25 SELL -225 127.780 128.610 128.527 USD -28,919 119.46 Loss of -2,041 on sale
2025-06-23 SELL -681 125.800 127.990 127.771 USD -87,012 119.36 Loss of -5,730 on sale
2025-06-20 SELL -227 126.550 128.380 128.197 USD -29,101 119.31 Loss of -2,017 on sale
2025-06-16 SELL -2,302 125.000 126.000 125.900 USD -289,822 119.13 Loss of -15,594 on sale
2025-06-13 SELL -226 124.390 125.540 125.425 USD -28,346 119.09 Loss of -1,432 on sale
2025-06-12 SELL -450 125.010 125.910 125.820 USD -56,619 119.05 Loss of -3,047 on sale
2025-06-11 SELL -1,125 124.170 125.510 125.376 USD -141,048 119.01 Loss of -7,157 on sale
2025-06-09 SELL -225 125.730 126.890 126.774 USD -28,524 118.93 Loss of -1,766 on sale
2025-05-30 SELL -33,038 123.020 123.930 123.839 USD -4,091,393 118.68 Loss of -170,365 on sale
2025-05-28 SELL -323 123.030 124.300 124.173 USD -40,108 118.61 Loss of -1,796 on sale
2025-05-21 SELL -323 120.560 122.420 122.234 USD -39,482 118.54 Loss of -1,193 on sale
2025-05-14 SELL -4,290 118.780 121.850 121.543 USD -521,419 118.43 Loss of -13,337 on sale
2025-05-09 BUY 1,670 115.710 119.670 119.274 USD 199,188 118.45
2025-05-07 SELL -1,288 121.610 122.570 122.474 USD -157,747 118.43 Loss of -5,203 on sale
2025-05-01 BUY 322 106.590 109.550 109.254 USD 35,180 118.68
2025-04-29 SELL -3,531 107.240 108.590 108.455 USD -382,955 118.88 Profit of 36,809 on sale
2025-04-28 SELL -323 106.460 108.330 108.143 USD -34,930 118.99 Profit of 3,503 on sale
2025-04-25 BUY 323 106.730 107.540 107.459 USD 34,709 119.10
2025-04-23 BUY 1,050 103.220 106.200 105.902 USD 111,197 119.36
2025-04-22 BUY 2,925 101.740 102.680 102.586 USD 300,064 119.53
2025-04-15 SELL -972 96.160 98.520 98.284 USD -95,532 120.28 Profit of 21,379 on sale
2025-04-14 BUY 1,708 94.890 95.560 95.493 USD 163,102 120.52
2025-04-11 BUY 1,642 90.870 91.280 91.239 USD 149,814 120.81
2025-04-09 SELL -969 95.280 95.560 95.532 USD -92,571 121.36 Profit of 25,029 on sale
2025-04-08 SELL -1,292 87.540 96.000 95.154 USD -122,939 121.70 Profit of 34,298 on sale
2025-04-07 SELL -323 93.250 96.440 96.121 USD -31,047 121.99 Profit of 8,355 on sale
2025-04-04 BUY 324 95.650 100.520 100.033 USD 32,411 122.26
2025-04-01 BUY 1,296 107.000 110.890 110.501 USD 143,209 122.56
2025-03-31 BUY 2,914 110.600 112.600 112.400 USD 327,534 122.69
2025-03-27 SELL -632 114.000 115.800 115.620 USD -73,072 122.88 Profit of 4,590 on sale
2025-03-21 SELL -316 111.920 112.530 112.469 USD -35,540 123.26 Profit of 3,409 on sale
2025-03-14 BUY 951 110.750 111.270 111.218 USD 105,768 124.02
2025-03-13 BUY 317 108.990 110.210 110.088 USD 34,898 124.20
2025-03-12 BUY 634 109.070 109.560 109.511 USD 69,430 124.38
2025-03-11 BUY 634 107.220 110.070 109.785 USD 69,604 124.60
2025-03-10 SELL -316 110.870 113.870 113.570 USD -35,888 124.77 Profit of 3,539 on sale
2025-03-07 BUY 5,355 113.040 115.000 114.804 USD 614,775 124.92
2025-03-05 BUY 1,580 113.850 114.960 114.849 USD 181,461 125.06
2025-03-04 BUY 632 113.110 114.390 114.262 USD 72,214 125.21
2025-03-03 BUY 1,264 114.480 119.000 118.548 USD 149,845 125.35
2025-02-27 BUY 316 117.510 117.850 117.816 USD 37,230 125.55
2025-02-26 BUY 2,512 117.590 118.710 118.598 USD 297,918 125.66
2025-02-25 BUY 628 115.900 120.000 119.590 USD 75,103 125.79
2025-02-20 BUY 942 116.110 117.680 117.523 USD 110,707 126.11
2025-02-05 BUY 314 151.200 153.090 152.901 USD 48,011 126.71
2025-02-04 BUY 314 152.420 153.880 153.734 USD 48,272 126.26
2025-01-31 SELL -314 151.820 154.350 154.097 USD -48,386 125.36 Loss of -9,024 on sale
2025-01-30 BUY 314 153.290 154.610 154.478 USD 48,506 124.84
2025-01-29 SELL -314 150.680 153.340 153.074 USD -48,065 124.35 Loss of -9,018 on sale
2025-01-28 BUY 628 150.710 152.620 152.429 USD 95,725 123.85
2025-01-27 SELL -314 148.190 151.530 151.196 USD -47,476 123.37 Loss of -8,738 on sale
2024-12-10 SELL -317 128.960 130.480 130.328 USD -41,314 122.22 Loss of -2,570 on sale
2024-12-03 SELL -634 125.440 126.980 126.826 USD -80,408 121.62 Loss of -3,300 on sale
2024-11-29 SELL -316 126.750 127.080 127.047 USD -40,147 121.39 Loss of -1,787 on sale
2024-11-22 SELL -951 125.650 127.000 126.865 USD -120,649 120.44 Loss of -6,114 on sale
2024-11-05 SELL -2,528 121.530 122.000 121.953 USD -308,297 118.24 Loss of -9,397 on sale
2024-11-05 SELL -2,528 121.530 122.000 121.953 USD -308,297 118.24 Loss of -9,397 on sale
2024-10-29 BUY 316 116.190 116.860 116.793 USD 36,907 115.99
2024-10-29 BUY 316 116.190 116.860 116.793 USD 36,907 115.99
2024-10-24 BUY 316 115.520 117.570 117.365 USD 37,087 116.06
2024-10-24 BUY 316 115.520 117.570 117.365 USD 37,087 116.06
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-04	SELL	-220	143.870	140.820	141.125	USD -31,048	124.42 Loss of -3,676 on sale
2025-10-31	BUY	104	143.470	137.065	137.706	USD 14,321	124.25
2025-10-28	SELL	-208	147.380	149.980	149.720	USD -31,142	124.01 Loss of -5,348 on sale
2025-10-21	SELL	-208	142.650	142.970	142.938	USD -29,731	123.52 Loss of -4,039 on sale
2025-10-14	SELL	-104	137.230	138.600	138.463	USD -14,400	123.14 Loss of -1,594 on sale
2025-10-02	SELL	-414	136.740	137.630	137.541	USD -56,942	122.92 Loss of -6,054 on sale
2025-09-25	SELL	-104	140.890	145.610	145.138	USD -15,094	122.47 Loss of -2,357 on sale
2025-09-16	BUY	95	140.900	141.020	141.008	USD 13,396	122.15
2025-09-12	SELL	-412	141.870	144.040	143.823	USD -59,255	121.94 Loss of -9,014 on sale
2025-09-09	SELL	-226	144.170	144.210	144.206	USD -32,591	121.60 Loss of -5,108 on sale
2025-07-28	SELL	-251	133.710	134.440	134.367	USD -33,726	120.61 Loss of -3,453 on sale
2025-07-15	SELL	-928	131.240	136.250	135.749	USD -125,975	120.25 Loss of -14,380 on sale
2025-07-11	SELL	-464	133.460	135.000	134.846	USD -62,569	120.08 Loss of -6,850 on sale
2025-07-07	BUY	2,366	127.880	129.070	128.951	USD 305,098	119.81
2025-07-02	BUY	223	129.400	130.420	130.318	USD 29,061	119.63
2025-06-30	SELL	-675	125.690	127.360	127.193	USD -85,855	119.59 Loss of -5,130 on sale
2025-06-27	SELL	-741	125.420	127.260	127.076	USD -94,163	119.56 Loss of -5,573 on sale
2025-06-26	BUY	225	126.710	128.660	128.465	USD 28,905	119.51
2025-06-25	SELL	-225	127.780	128.610	128.527	USD -28,919	119.46 Loss of -2,041 on sale
2025-06-23	SELL	-681	125.800	127.990	127.771	USD -87,012	119.36 Loss of -5,730 on sale
2025-06-20	SELL	-227	126.550	128.380	128.197	USD -29,101	119.31 Loss of -2,017 on sale
2025-06-16	SELL	-2,302	125.000	126.000	125.900	USD -289,822	119.13 Loss of -15,594 on sale
2025-06-13	SELL	-226	124.390	125.540	125.425	USD -28,346	119.09 Loss of -1,432 on sale
2025-06-12	SELL	-450	125.010	125.910	125.820	USD -56,619	119.05 Loss of -3,047 on sale
2025-06-11	SELL	-1,125	124.170	125.510	125.376	USD -141,048	119.01 Loss of -7,157 on sale
2025-06-09	SELL	-225	125.730	126.890	126.774	USD -28,524	118.93 Loss of -1,766 on sale
2025-05-30	SELL	-33,038	123.020	123.930	123.839	USD -4,091,393	118.68 Loss of -170,365 on sale
2025-05-28	SELL	-323	123.030	124.300	124.173	USD -40,108	118.61 Loss of -1,796 on sale
2025-05-21	SELL	-323	120.560	122.420	122.234	USD -39,482	118.54 Loss of -1,193 on sale
2025-05-14	SELL	-4,290	118.780	121.850	121.543	USD -521,419	118.43 Loss of -13,337 on sale
2025-05-09	BUY	1,670	115.710	119.670	119.274	USD 199,188	118.45
2025-05-07	SELL	-1,288	121.610	122.570	122.474	USD -157,747	118.43 Loss of -5,203 on sale
2025-05-01	BUY	322	106.590	109.550	109.254	USD 35,180	118.68
2025-04-29	SELL	-3,531	107.240	108.590	108.455	USD -382,955	118.88 Profit of 36,809 on sale
2025-04-28	SELL	-323	106.460	108.330	108.143	USD -34,930	118.99 Profit of 3,503 on sale
2025-04-25	BUY	323	106.730	107.540	107.459	USD 34,709	119.10
2025-04-23	BUY	1,050	103.220	106.200	105.902	USD 111,197	119.36
2025-04-22	BUY	2,925	101.740	102.680	102.586	USD 300,064	119.53
2025-04-15	SELL	-972	96.160	98.520	98.284	USD -95,532	120.28 Profit of 21,379 on sale
2025-04-14	BUY	1,708	94.890	95.560	95.493	USD 163,102	120.52
2025-04-11	BUY	1,642	90.870	91.280	91.239	USD 149,814	120.81
2025-04-09	SELL	-969	95.280	95.560	95.532	USD -92,571	121.36 Profit of 25,029 on sale
2025-04-08	SELL	-1,292	87.540	96.000	95.154	USD -122,939	121.70 Profit of 34,298 on sale
2025-04-07	SELL	-323	93.250	96.440	96.121	USD -31,047	121.99 Profit of 8,355 on sale
2025-04-04	BUY	324	95.650	100.520	100.033	USD 32,411	122.26
2025-04-01	BUY	1,296	107.000	110.890	110.501	USD 143,209	122.56
2025-03-31	BUY	2,914	110.600	112.600	112.400	USD 327,534	122.69
2025-03-27	SELL	-632	114.000	115.800	115.620	USD -73,072	122.88 Profit of 4,590 on sale
2025-03-21	SELL	-316	111.920	112.530	112.469	USD -35,540	123.26 Profit of 3,409 on sale
2025-03-14	BUY	951	110.750	111.270	111.218	USD 105,768	124.02
2025-03-13	BUY	317	108.990	110.210	110.088	USD 34,898	124.20
2025-03-12	BUY	634	109.070	109.560	109.511	USD 69,430	124.38
2025-03-11	BUY	634	107.220	110.070	109.785	USD 69,604	124.60
2025-03-10	SELL	-316	110.870	113.870	113.570	USD -35,888	124.77 Profit of 3,539 on sale
2025-03-07	BUY	5,355	113.040	115.000	114.804	USD 614,775	124.92
2025-03-05	BUY	1,580	113.850	114.960	114.849	USD 181,461	125.06
2025-03-04	BUY	632	113.110	114.390	114.262	USD 72,214	125.21
2025-03-03	BUY	1,264	114.480	119.000	118.548	USD 149,845	125.35
2025-02-27	BUY	316	117.510	117.850	117.816	USD 37,230	125.55
2025-02-26	BUY	2,512	117.590	118.710	118.598	USD 297,918	125.66
2025-02-25	BUY	628	115.900	120.000	119.590	USD 75,103	125.79
2025-02-20	BUY	942	116.110	117.680	117.523	USD 110,707	126.11
2025-02-05	BUY	314	151.200	153.090	152.901	USD 48,011	126.71
2025-02-04	BUY	314	152.420	153.880	153.734	USD 48,272	126.26
2025-01-31	SELL	-314	151.820	154.350	154.097	USD -48,386	125.36 Loss of -9,024 on sale
2025-01-30	BUY	314	153.290	154.610	154.478	USD 48,506	124.84
2025-01-29	SELL	-314	150.680	153.340	153.074	USD -48,065	124.35 Loss of -9,018 on sale
2025-01-28	BUY	628	150.710	152.620	152.429	USD 95,725	123.85
2025-01-27	SELL	-314	148.190	151.530	151.196	USD -47,476	123.37 Loss of -8,738 on sale
2024-12-10	SELL	-317	128.960	130.480	130.328	USD -41,314	122.22 Loss of -2,570 on sale
2024-12-03	SELL	-634	125.440	126.980	126.826	USD -80,408	121.62 Loss of -3,300 on sale
2024-11-29	SELL	-316	126.750	127.080	127.047	USD -40,147	121.39 Loss of -1,787 on sale
2024-11-22	SELL	-951	125.650	127.000	126.865	USD -120,649	120.44 Loss of -6,114 on sale
2024-11-05	SELL	-2,528	121.530	122.000	121.953	USD -308,297	118.24 Loss of -9,397 on sale
2024-11-05	SELL	-2,528	121.530	122.000	121.953	USD -308,297	118.24 Loss of -9,397 on sale
2024-10-29	BUY	316	116.190	116.860	116.793	USD 36,907	115.99
2024-10-29	BUY	316	116.190	116.860	116.793	USD 36,907	115.99
2024-10-24	BUY	316	115.520	117.570	117.365	USD 37,087	116.06
2024-10-24	BUY	316	115.520	117.570	117.365	USD 37,087	116.06

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of NBIX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	138,304	0	280,714	49.3%
2025-09-18	207,776	44,506	326,194	63.7%
2025-09-17	106,323	343	194,597	54.6%
2025-09-16	97,811	19,146	256,980	38.1%
2025-09-15	73,363	0	197,457	37.2%
2025-09-12	71,817	1,305	193,968	37.0%
2025-09-11	87,204	0	250,369	34.8%
2025-09-10	117,099	0	288,605	40.6%
2025-09-09	123,379	1,879	226,941	54.4%
2025-09-08	213,669	1,667	350,787	60.9%
2025-09-05	269,882	8,988	447,930	60.3%
2025-09-04	193,322	481	275,129	70.3%
2025-09-03	210,597	108	556,905	37.8%
2025-09-02	183,319	15,512	318,150	57.6%
2025-08-29	101,061	7,590	154,079	65.6%
2025-08-28	127,383	487	193,561	65.8%
2025-08-27	137,454	1,818	217,033	63.3%
2025-08-26	170,022	3,558	291,096	58.4%
2025-08-25	124,153	3,639	195,476	63.5%
2025-08-22	126,629	10,885	196,288	64.5%
2025-08-21	119,245	1,265	200,990	59.3%
2025-08-20	135,138	4,637	230,010	58.8%
2025-08-19	186,010	535	287,330	64.7%
2025-08-18	162,038	7,351	232,609	69.7%
2025-08-15	140,024	100	220,199	63.6%
2025-08-14	290,907	253	363,139	80.1%
2025-08-13	356,404	8,730	466,191	76.5%
2025-08-12	303,975	4,067	434,641	69.9%
2025-08-11	279,191	5,617	413,027	67.6%
2025-08-08	338,385	0	490,220	69.0%
2025-08-07	341,719	2	486,060	70.3%
2025-08-06	162,494	52	290,741	55.9%
2025-08-05	127,812	122	285,401	44.8%
2025-08-04	184,650	798	554,601	33.3%
2025-08-01	384,652	274	613,137	62.7%
2025-07-31	795,027	2	1,403,519	56.6%
2025-07-30	277,359	199	566,942	48.9%
2025-07-29	235,483	1,232	479,504	49.1%
2025-07-28	128,796	1,272	304,763	42.3%
2025-07-25	164,959	0	533,682	30.9%
2025-07-24	143,137	442	360,991	39.7%
2025-07-23	127,087	250	336,567	37.8%
2025-07-22	110,378	700	199,614	55.3%
2025-07-21	94,768	91	171,481	55.3%
2025-07-18	136,185	216	238,836	57.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.